| P2093 | author name string | G Thomas | |
| | D E Hruby | |
| P2860 | cites work | Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes | Q27860623 |
| | A new technique for the assay of infectivity of human adenovirus 5 DNA | Q27860797 |
| | Efficientin vitrosynthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter | Q27861016 |
| | Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter | Q29614259 |
| | Vaccinia Virus Replication I. Requirement for the Host-Cell Nucleus | Q30850654 |
| | Hepatitis B virus large surface protein is not secreted but is immunogenic when selectively expressed by recombinant vaccinia virus | Q33926692 |
| | Resistance to human respiratory syncytial virus (RSV) infection induced by immunization of cotton rats with a recombinant vaccinia virus expressing the RSV G glycoprotein | Q35596022 |
| | Construction of live vaccines using genetically engineered poxviruses: biological activity of vaccinia virus recombinants expressing the hepatitis B virus surface antigen and the herpes simplex virus glycoprotein D. | Q36245488 |
| | Molecular genetics of vaccinia virus: demonstration of marker rescue | Q36285469 |
| | Expression of Sindbis virus structural proteins via recombinant vaccinia virus: synthesis, processing, and incorporation into mature Sindbis virions | Q36851214 |
| | Neomycin resistance as a dominant selectable marker for selection and isolation of vaccinia virus recombinants | Q36891780 |
| | General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes. | Q36913229 |
| | Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques | Q36952733 |
| | Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity | Q37401975 |
| | Immune responses to H-2Kd antigen expressed by recombinant vaccinia virus | Q37403896 |
| | Construction and characterization of an infectious vaccinia virus recombinant that expresses the influenza hemagglutinin gene and induces resistance to influenza virus infection in hamsters | Q37508631 |
| | Modification and secretion of human interleukin 2 produced in insect cells by a baculovirus expression vector | Q37539177 |
| | High-efficiency gene transfer into mammalian cells: generation of helper-free recombinant retrovirus with broad mammalian host range | Q37572832 |
| | Transfer of genes into hematopoietic cells using recombinant DNA viruses | Q37672708 |
| | Overproduction of the protein product of a nonselected foreign gene carried by an adenovirus vector | Q37689369 |
| | T-lymphocyte priming and protection against Friend leukemia by vaccinia-retrovirus env gene recombinant | Q38981461 |
| | Expression of the HTLV-III envelope gene by a recombinant vaccinia virus | Q39500655 |
| | Polyprotein gene expression: generation of diversity of neuroendocrine peptides | Q40186661 |
| | Recombinant vaccinia virus induces neutralising antibodies in rabbits against Epstein-Barr virus membrane antigen gp340. | Q41430227 |
| | Vaccinia virus recombinants: expression of VSV genes and protective immunization of mice and cattle | Q41773463 |
| | Expression of recombinant vaccinia virus-derived alphavirus proteins in mosquito cells | Q42994599 |
| | Recombinant vaccinia virus: immunization against multiple pathogens | Q43736710 |
| | Use of vaccinia virus as a neuropeptide expression vector | Q45071816 |
| | Efficient targeted insertion of an unselected marker into the vaccinia virus genome | Q45184382 |
| | Plasmodium knowlesi sporozoite antigen: expression by infectious recombinant vaccinia virus | Q45804460 |
| | Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype | Q45827796 |
| | Immunisation of cattle with a recombinant togavirus-vaccinia virus strain | Q45828884 |
| | T-cell responses to human AIDS virus in macaques immunized with recombinant vaccinia viruses | Q45834058 |
| | Expression and cell type--specific processing of human preproenkephalin with a vaccinia recombinant | Q46213206 |
| | The use of pKc30 and its derivatives for controlled expression of genes | Q70160194 |
| | Plasmids containing the trp promoters of Escherichia coli and Serratia marcescens and their use in expressing cloned genes | Q70160203 |
| | Construction and use of gene fusions to lacZ (beta-galactosidase) that are expressed in yeast | Q70160206 |
| | Infectious poxvirus vectors have capacity for at least 25 000 base pairs of foreign DNA | Q72804855 |
| P433 | issue | 2 | |
| P921 | main subject | Vaccinia virus | Q1986297 |
| P304 | page(s) | 92-97 | |
| P577 | publication date | 1987-04-01 | |
| P1433 | published in | Pharmaceutical Research | Q7180737 |
| P1476 | title | Use of vaccinia virus to express biopharmaceutical products | |
| P478 | volume | 4 | |